134 related articles for article (PubMed ID: 6523885)
1. [Antiarrhythmic effect and side effects of amiodarone].
Weber H; Weissel M; Haddad R; Scheibelhofer W; Konrad K; Mlczoch J; Probst P; Mainitz M
Wien Klin Wochenschr; 1984 Sep; 96(18):685-96. PubMed ID: 6523885
[TBL] [Abstract][Full Text] [Related]
2. Clinical efficacy of amiodarone in treatment of recurrent ventricular tachycardia and ventricular fibrillation.
Heger JJ; Prystowsky EN; Zipes DP
Am Heart J; 1983 Oct; 106(4 Pt 2):887-94. PubMed ID: 6613835
[TBL] [Abstract][Full Text] [Related]
3. Amiodarone for refractory cardiac arrhythmias: 10-year study.
Leak D; Eydt JN
CMAJ; 1986 Mar; 134(5):495-501. PubMed ID: 3948063
[TBL] [Abstract][Full Text] [Related]
4. Long term efficacy and toxicity of amiodarone in the treatment of refractory cardiac arrhythmias.
Primeau R; Agha A; Giorgi C; Shenasa M; Nadeau R
Can J Cardiol; 1989 Mar; 5(2):98-104. PubMed ID: 2706579
[TBL] [Abstract][Full Text] [Related]
5. Clinical efficacy and electrophysiology during long-term therapy for recurrent ventricular tachycardia or ventricular fibrillation.
Heger JJ; Prystowsky EN; Jackman WM; Naccarelli GV; Warfel KA; Rinkenberger RL; Zipes DP
N Engl J Med; 1981 Sep; 305(10):539-45. PubMed ID: 6789201
[TBL] [Abstract][Full Text] [Related]
6. Amiodarone: a unique antiarrhythmic agent.
Sloskey GE
Clin Pharm; 1983; 2(4):330-40. PubMed ID: 6349912
[TBL] [Abstract][Full Text] [Related]
7. Long-term efficacy, safety and survival of patients with potentially lethal ventricular arrhythmias treated with low-dose amiodarone.
Kerin NZ; Rubenfire M; Blevins RD; Frumin H; Faitel K; Jarandilla R; Aragon E; Marinescu G; Luarca R
Clin Cardiol; 1988 Mar; 11(3 Suppl 2):II31-40. PubMed ID: 3271193
[TBL] [Abstract][Full Text] [Related]
8. [Anti-arrhythmic efficacy of the amiodarone-mexiletine combination in the treatment of resistant complex ventricular arrhythmias].
Purcaro A; Massacci C; Curzi G; Pigini G; Costantini C; Bilancini A; Blandini A
G Ital Cardiol; 1986 May; 16(5):417-26. PubMed ID: 3732727
[TBL] [Abstract][Full Text] [Related]
9. [Anti-arrhythmic effect of amiodarone in the 24 hours following a single oral loading dose. Clinical and pharmacological study].
Escoubet B; Poirier JM; Maison-Blanche P; Jaillon P; Leclercq JF; Coumel P; Slama R
Arch Mal Coeur Vaiss; 1985 Jul; 78(7):1046-52. PubMed ID: 3929732
[TBL] [Abstract][Full Text] [Related]
10. Amiodarone in long term management of refractory cardiac tachyarrhythmias.
Lubbe WF; Mercer CJ; Roche AH; Lowe JB
N Z Med J; 1981 Jan; 93(676):31-5. PubMed ID: 6940024
[TBL] [Abstract][Full Text] [Related]
11. [Value of a serial electropharmacologic study in survivors of a cardiac arrest secondary to ventricular tachycardia or ventricular fibrillation].
Raviele A; Di Pede F; Delise P; Piccolo E
G Ital Cardiol; 1984 Sep; 14(9):644-54. PubMed ID: 6510619
[TBL] [Abstract][Full Text] [Related]
12. Amiodarone in the treatment of patients with refractory symptomatic ventricular and supraventricular arrhythmias. A long-term follow-up study.
Lloyd EA; Mabin TA
S Afr Med J; 1983 May; 63(20):759-63. PubMed ID: 6342169
[TBL] [Abstract][Full Text] [Related]
13. Clinical value of cordarone as an antiarrhythmic agent.
Piwowarska W; Sniezek-Maciejewska M
Cor Vasa; 1987; 29(4):269-77. PubMed ID: 2445525
[TBL] [Abstract][Full Text] [Related]
14. [Electrocardiographic effects and antiarrhythmic action of 1200 mg of oral amiodarone per day].
Tonet JL; Lechat P; Frank R; Lascault G; Fontaine G; Facquet J; Cohen A; Grosgogeat Y
Ann Cardiol Angeiol (Paris); 1984; 33(5):309-15. PubMed ID: 6476769
[TBL] [Abstract][Full Text] [Related]
15. Toxic and therapeutic effects of amiodarone in the treatment of cardiac arrhythmias.
Greene HL; Graham EL; Werner JA; Sears GK; Gross BW; Gorham JP; Kudenchuk PJ; Trobaugh GB
J Am Coll Cardiol; 1983 Dec; 2(6):1114-28. PubMed ID: 6685151
[TBL] [Abstract][Full Text] [Related]
16. Long-term efficacy and toxicity of high-dose amiodarone therapy for ventricular tachycardia or ventricular fibrillation.
Morady F; Sauve MJ; Malone P; Shen EN; Schwartz AB; Bhandari A; Keung E; Sung RJ; Scheinman MM
Am J Cardiol; 1983 Nov; 52(8):975-9. PubMed ID: 6637851
[TBL] [Abstract][Full Text] [Related]
17. Ventricular arrhythmias: use of electrophysiologic studies.
Horowitz LN; Spielman SR; Greenspan AM; Webb CR; Kay HR
Am Heart J; 1983 Oct; 106(4 Pt 2):881-6. PubMed ID: 6613834
[TBL] [Abstract][Full Text] [Related]
18. Short- and intermediate-term efficacy of amiodarone in infants and children with cardiac arrhythmia.
Celiker A; Koçak G; Lenk MK; Alehan D; Ozme S
Turk J Pediatr; 1997; 39(2):219-25. PubMed ID: 9223920
[TBL] [Abstract][Full Text] [Related]
19. High incidence of clinical and subclinical toxicity associated with amiodarone treatment of refractory tachyarrhythmias.
Anastasiou-Nana MI; Anderson JL; Nanas JN; Lutz JR; Smith RA; Anderson KP; Crapo RO; Call NB
Can J Cardiol; 1986; 2(3):138-45. PubMed ID: 2941121
[TBL] [Abstract][Full Text] [Related]
20. Nonsustained ventricular tachycardia as a predictor for sudden death in patients with idiopathic dilated cardiomyopathy. The role of amiodarone treatment.
Castelli G; Ciaccheri M; Cecchi F; Troiani V; Nannini M; Marconi P; Olivotto J; Montereggi A; Dolara A
G Ital Cardiol; 1999 May; 29(5):514-23. PubMed ID: 10367218
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
